Technology | April 08, 2011

Compact Camera Designed to Maximize Revenues and Efficiency

April 8, 2011 – The U.S. Food and Drug Administration (FDA) has cleared a next-generation compact gamma camera. MedX’s T-Quest includes enhanced thyroid imaging and features expanded imaging capabilities to perform parathyroid, sentinel node, MUGA, gastric emptying, hepatobiliary, bone spots and other small organ studies.

The company also announced the first installations for the device at two leading acute care hospitals, Meritus Medical Center in Hagerstown, Md. and St. Barnabas Medical Center in Livingston, N.J.

The image quality and low lifetime system cost, offers medium to large hospitals and imaging centers a cost-effective tool to expand volume, improve efficiency and provide quality patient care.

Commercially available worldwide, the camera provides high-quality imaging capabilities and the freedom to perform long duration time/activity studies. Its minimized focal distance and mm/pixel ratio maximizes diagnostic quality through improved image resolution. The results of this combination are increased operating efficiency, better imaging economics and improved diagnostic results.

It requires less than 8 square feet of floor space, and features a 6-inch field of view and lightweight collimators, which are easily changed by hand. Its unobtrusive design promotes patient comfort and is non-claustrophobic.

The system works in conjunction with the NuQuest acquisition and processing computer, providing a comprehensive, standalone system. The onboard NuQuest computer provides state-of-the-art energy, linearity and uniformity corrections for superior image quality. The software features customizable imaging acquisition protocols along with a host of general nuclear image processing tools. It also features an intuitive user interface with simple pull-down menus and features DICOM 3.0 print, file export and modality worklist capabilities.

For more information: www.medx-inc.com

Related Content

NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
Improving Molecular Imaging Using a Deep Learning Approach
News | Nuclear Imaging | March 21, 2019
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Researchers Create New Method for Developing Cancer Imaging Isotopes

Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory

News | Radiopharmaceuticals and Tracers | March 14, 2019
A team of researchers at the University of Washington announced they developed a new automated system for producing...
Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT
News | PET-CT | March 06, 2019
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been...
ImaginAb Enrolls First Patient in Phase II PET Agent Clinical Trial
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...
FDA Clears United Imaging Healthcare uExplorer Total-Body Scanner
Technology | PET-CT | January 23, 2019
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S.
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...